Mechanisms of Acquired Androgen Independence during Arsenic-Induced Malignant Transformation of Human Prostate Epithelial Cells
- 1 February 2007
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 115 (2), 243-247
- https://doi.org/10.1289/ehp.9630
Abstract
Prostate cancer progression often occurs with overexpression of growth factors and receptors, many of which engage the Ras/mitogen-activated protein MAP kinase (MAPK) pathway. In this study we used arsenic-transformed human prostate epithelial cells, which also show androgen-independent growth, to study the possibility that chronic activation of Ras/MAPK signaling may contribute to arsenic-induced prostate cancer progression. Control and chronic arsenic–transformed prostate epithelial cells (CAsE-PE) were compared for Ras/MAPK signaling capacities using reverse transcription–polymerase chain reaction and Western blot analyses. We found activation of HER-2/neu oncogene in transformed CAsE-PE cells, providing molecular evidence of androgen independence in the transformed cells. CAsE-PE cells displayed constitutively increased expression of unmutated K-Ras (6-fold), and the downstream MAP kinases A-Raf and B-Raf (2.2-fold and 3.2-fold, respectively). There was also increased expression of phosphorylated MEK1/2 and Elk1 in the transformant cells. The MEK1/2 inhibitor, U0126, blocked PSA overexpression in CAsE-PE cells. Thus, arsenic-induced malignant transformation and acquired androgen independence are linked to Ras signaling activation in human prostate epithelial cells. Chronic activation of this pathway can sensitize the androgen receptor to subphysiologic levels of androgen. This may be important in arsenic carcinogenesis and provide a mechanism that may be common for prostate cancer progression driven by diverse agents.Keywords
This publication has 48 references indexed in Scilit:
- Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observationsBJU International, 2006
- Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft modelMolecular Cancer Therapeutics, 2005
- Acquisition of Androgen Independence by Human Prostate Epithelial Cells during Arsenic-Induced Malignant TransformationEnvironmental Health Perspectives, 2005
- Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activationToxicology and Applied Pharmacology, 2005
- Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasmsGynecologic Oncology, 2004
- Prostate specific antigen gene regulation by androgen receptorJournal of Cellular Biochemistry, 2004
- Her-2/neu Expression in Prostate CancerClinical Cancer Research, 2004
- Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapyJournal of Cellular Biochemistry, 2004
- Ras signaling in prostate cancer progressionJournal of Cellular Biochemistry, 2003
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003